The osteoblast-specific transcription factor Cbfa1 contributes to the expression of osteoprotegerin, a potent inhibitor of osteoclast differentiation and function

被引:156
作者
Thirunavukkarasu, K
Halladay, DL
Miles, RR
Yang, XH
Galvin, RJS
Chandrasekhar, S
Martin, TJ
Onyia, JE
机构
[1] Eli Lilly & Co, Lilly Res Labs, Div Endocrine, Indianapolis, IN 46285 USA
[2] St Vincents Inst Med Res, Fitzroy, Vic 3065, Australia
关键词
D O I
10.1074/jbc.M000322200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Bone formation and resorption are tightly coupled under normal conditions, and the interaction of osteoclast precursors with cells of the osteoblast lineage is a prerequisite for osteoclast formation. Cbfa1 is an osteoblast-specific transcription factor that is essential for osteoblast differentiation and bone formation. At present, it is not known whether Cbfa1 regulates any of the osteoblast-derived factors involved in the bone resorption pathway. Osteoprotegerin (OPG) is an osteoblast-secreted glycoprotein that functions as a potent inhibitor of osteoclast differentiation and bone resorption, Cloning and computer analysis of a 5,9-kilobase human OPG promoter sequence revealed the presence of 12 putative Cbfa1 binding elements (osteoblast-specific element 2 (OSE2)), suggesting a possible regulation of OPG by Cbfa1, We cloned the promoter upstream of the beta-galactosidase reporter gene (pOPGEi.Bpgal) and evaluated whether Cbfa1 could regulate its expression in transient transfection assays. The 5,9-kilobase promoter directed increased levels of reporter gene expression, reminiscent of OPG protein levels in osteoblastic cell lines (BALC and U2OS) as compared with the nonosteoblastic cell line COS1, Cotransfection of a Cbfa1 expression construct along with pOPG5.9 beta gal reporter construct led to 39-, 7-, and 16-fold increases in beta-galactosidase activity in COS1, BALC, and U2OS cells, respectively. Removal of all the putative OSE2 elements led to an almost complete loss of transactivation, Mutational analysis demonstrated that the proximal OSE, element contributes to a majority of the effects of Cbfa1, and Cbfa1 bound to the proximal element in a sequence-specific manner. Further, overexpression of Cbfa1 led to a 54% increase in OPG protein levels in U2OS cells. These results indicate that Cbfa1 regulates the expression of OPG, thereby further contributing to a molecular link between bone formation and resorption.
引用
收藏
页码:25163 / 25172
页数:10
相关论文
共 48 条
[41]   Osteoprotegerin: A novel secreted protein involved in the regulation of bone density [J].
Simonet, WS ;
Lacey, DL ;
Dunstan, CR ;
Kelley, M ;
Chang, MS ;
Luthy, R ;
Nguyen, HQ ;
Wooden, S ;
Bennett, L ;
Boone, T ;
Shimamoto, G ;
DeRose, M ;
Elliott, R ;
Colombero, A ;
Tan, HL ;
Trail, G ;
Sullivan, J ;
Davy, E ;
Bucay, N ;
RenshawGegg, L ;
Hughes, TM ;
Hill, D ;
Pattison, W ;
Campbell, P ;
Sander, S ;
Van, G ;
Tarpley, J ;
Derby, P ;
Lee, R ;
Boyle, WJ .
CELL, 1997, 89 (02) :309-319
[42]   MODULATION OF OSTEOCLAST DIFFERENTIATION [J].
SUDA, T ;
TAKAHASHI, N ;
MARTIN, TJ .
ENDOCRINE REVIEWS, 1992, 13 (01) :66-80
[43]   Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families [J].
Suda, T ;
Takahashi, N ;
Udagawa, N ;
Jimi, E ;
Gillespie, MT ;
Martin, TJ .
ENDOCRINE REVIEWS, 1999, 20 (03) :345-357
[44]   Cryptic enhancer elements in luciferase reporter vectors respond to the osteoblast-specific transcription factor Osf2/Cbfa1 [J].
Thirunavukkarasu, K ;
Miles, RR ;
Halladay, DL ;
Onyia, JE .
BIOTECHNIQUES, 2000, 28 (03) :506-510
[45]   Two domains unique to osteoblast-specific transcription factor Osf2/Cbfa1 contribute to its transactivation function and its inability to heterodimerize with Cbfβ [J].
Thirunavukkarasu, K ;
Mahajan, M ;
McLarren, KW ;
Stifani, S ;
Karsenty, G .
MOLECULAR AND CELLULAR BIOLOGY, 1998, 18 (07) :4197-4208
[46]   TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells [J].
Wong, BR ;
Rho, JR ;
Arron, J ;
Robinson, E ;
Orlinick, J ;
Chao, M ;
Kalachikov, S ;
Cayani, E ;
Bartlett, FS ;
Frankel, WN ;
Lee, SY ;
Choi, YW .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (40) :25190-25194
[47]   TRANCE (tumor necrosis factor [TNF]-related activation-induced cytokine), a new TNF family member predominantly expressed in T cells, is a dendritic cell-specific survival factor [J].
Wong, BR ;
Josien, R ;
Lee, SY ;
Sauter, B ;
Li, HL ;
Steinman, RM ;
Choi, YW .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (12) :2075-2080
[48]   Osteoclast differentiation factor is a ligand for osteoprotegerin osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL [J].
Yasuda, H ;
Shima, N ;
Nakagawa, N ;
Yamaguchi, K ;
Kinosaki, M ;
Mochizuki, S ;
Tomoyasu, A ;
Yano, K ;
Goto, M ;
Murakami, A ;
Tsuda, E ;
Morinaga, T ;
Higashio, K ;
Udagawa, N ;
Takahashi, N ;
Suda, T .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (07) :3597-3602